Label-free cell-based assays for GPCR screening.
G protein-coupled receptors (GPCRs) have been proven to be the largest family of druggable targets in the human genome. Given the importance of GPCRs as drug targets and the de-orphanization of novel targets, GPCRs are likely to remain the frequent targets of many drug discovery programs. With recent advances in instrumentation and understanding of cellular mechanisms for the signals measured, biosensor-centered label-free cell assay technologies become a very active area for GPCR screening. This article reviews the principles and potential of current label-free cell assay technologies in GPCR drug discovery.
Fang
Ye
Y
Biochemical Technologies, Science and Technology Division, Corning Incorporated, Corning, NY 14831, USA. fangy2@corning.com
Frutos
Anthony G
AG
Verklereen
Ronald
R
D000818:Animals; D001681:Biological Assay / Q000295:instrumentation / Q000379:methods*; D002477:Cells / Q000378:metabolism; D055808:Drug Discovery / Q000295:instrumentation / Q000379:methods*; D004563:Electrochemistry; D006801:Humans; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D015398:Signal Transduction; D013194:Staining and Labeling
D043562:Receptors, G-Protein-Coupled